The rising challenge of non-AIDS-defining cancers in HIV-infected patients
about
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsLung cancer in HIV-infected patients in the combination antiretroviral treatment eraManagement of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapyThe evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careEpstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infectionSpontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature ReviewSevere morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine CohortAlcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future DirectionsThe comparison of the pathological data of oropharyngeal masses between HIV and non-HIV patients.Long-term nitrite inhalant exposure and cancer risk in MSM.A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patientsPharmacotherapy in cancer patients with HIV/AIDSCancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysisCancer treatment disparities in HIV-infected individuals in the United States.Residual immune dysregulation syndrome in treated HIV infection.Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious DiseasToxicity and disease-related outcomes after radiotherapy for head and neck cancer in human immunodeficiency virus-positive patientsThe quantum of initial transformed cells potentially modulates the type of local inflammation mechanism elicited by surrounding normal epithelial tissues and systemic immune pattern for tumor arrest or progression.Management of HIV infection in patients with cancer receiving chemotherapy.Sexual risk behaviors and HIV risk among Americans aged 50 years or older: a reviewThe changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin's lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study.Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study.Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.Prevalence and mortality of cancer among HIV-infected inpatients in Beijing, ChinaPreclinical assessment of the interactions between the antiretroviral drugs, ritonavir and efavirenz, and the tyrosine kinase inhibitor erlotinib.Association between the COMT 158 G/A polymorphism and lung cancer risk: a meta-analysis.The role of viral co-infection in HIV-associated non-AIDS-related cancersTreatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations.Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer.HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.Serious Non-AIDS events: Immunopathogenesis and interventional strategies.Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity.Colorectal Cancer Screening at the Nexus of HIV, Minority Statuses, and Cultural SafetyCombination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure.Heat shock protein 90 controls HIV-1 reactivation from latency.Non-AIDS-defining cancers among HIV-infected patients.
P2860
Q26740117-7A7EDDFB-8BEC-4C39-9A6E-24BA8CCF6E5AQ26769769-C4D59318-1F74-40AC-89FD-F56B668AD4DBQ26775832-DAD1FE5B-4521-44F3-9194-84992C5A937EQ26991549-44906ECC-E689-43F6-BC8E-EC405FA4A75FQ27022706-06BF1FE3-08E2-4D1B-9A98-39FFF7BAEB16Q28081273-12EAD2C4-A29F-4BAE-8577-E539EA4FBE3BQ28541356-5ECF0A84-645F-47AD-9304-7C943D87AFFEQ30244921-C1C0CA40-0419-483D-9932-B61FBD5E138BQ31082855-ADDC3D34-0459-4EC9-9FE3-3A0B3D46BE59Q33631041-391CF664-30F4-4CA7-8FAB-E1B3A1A8C5CAQ33686288-CF2E6159-64ED-4264-A095-76E3481FC5A0Q33816061-B967813F-C5D3-4413-A51A-F43A73D4EAC2Q33881799-30BEE4BE-0DBB-4E44-8164-7999EA7A4ED5Q33884821-13DD66D3-61F1-44C4-88E4-431B29E2AA89Q33927996-C4F80520-3AAE-4B52-B889-17043E87431AQ34020121-F5E2664C-9061-4D0A-B498-A69D2A52FC02Q34407741-74314EFB-272F-48CF-A90A-58BAC05084B3Q34481497-B5612546-B51A-465D-A18B-3DF6BE712369Q34791671-58C853C0-F381-496A-9A27-85AAFD6D4D73Q35008342-08FC2521-1CC8-45A1-A426-5424645525CBQ35541920-F6E67776-2786-4D5F-854B-35BC06BFDDA9Q35552875-C1AEFE79-1D75-45F1-8E25-171B92F19599Q35589818-6C0C35B5-9686-4B0B-98A3-8712BC6D07B9Q35605347-A262D700-52FC-4AAE-B584-3F7D03D5D750Q35666172-051AD936-8506-47CB-BCFC-36854BFAD7ABQ35864285-346BF220-7CDB-40A7-BB98-56118F84D86AQ35921020-C3F106AC-7956-4187-8125-036EB5502873Q35925376-B73D0673-A49A-41CD-A44B-B8603AA3E615Q36080621-461E1D05-D7C9-47A0-A4AB-906DA53384AEQ36411618-A4158076-9003-4D2E-A874-1C7FEE486DCDQ36960884-19A17B45-F4E4-4CD3-A0E6-10FD69280E16Q37157254-FC5FE629-117E-4DE1-9B7F-54C15A546474Q37193103-E3618D13-3F42-4B78-B539-EA61825F227FQ37300347-177479F7-3A63-4C23-972C-686FDA40A913Q37418140-728BE2D0-7974-41B9-9C8D-203409B3496EQ37422773-2606AEA0-9793-4B9D-BFAB-999A3DFEEB3CQ37641720-109B200B-867D-486E-88EA-635B4CF11130Q37669678-95733BEF-0A76-4384-8710-8180504B6813Q37711958-A5DEC563-25DD-4BC6-B6FF-9CE143D5F48EQ38112573-FAC5F052-DC73-449C-8048-0BB9DA3C6720
P2860
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@ast
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@en
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@nl
type
label
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@ast
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@en
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@nl
prefLabel
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@ast
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@en
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@nl
P2093
P2860
P3181
P356
P1476
The rising challenge of non-AIDS-defining cancers in HIV-infected patients
@en
P2093
A. Tjen-A-Looi
B. J. Dezube
C. Okuliar
J. F. Deeken
M. A. Rudek
R. F. Little
P2860
P304
P3181
P356
10.1093/CID/CIS613
P407
P577
2012-11-01T00:00:00Z